Laparoscopic adjustable gastric banding and other devices for the management of obesity

Circulation

Volumn 126, Issue 6, 2012, Pages 774-785

  Dixon, John B ^a   Straznicky, Nora E ^a   Lambert, Elisabeth A ^a   Schlaich, Markus P ^a   Lambert, Gavin W ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

bariatric surgery; insulin resistance; metabolic syndrome X; obesity; weight loss

Indexed keywords

ARTICLE; GASTRIC BANDING; HUMAN; MEDICAL DEVICE; OBESITY; PATIENT SAFETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; SURGICAL MORTALITY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; WEIGHT REDUCTION;

ANIMALS; DISEASE MANAGEMENT; GASTROPLASTY; HUMANS; LAPAROSCOPY; OBESITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; WEIGHT LOSS;

EID: 84864720629     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.040139     Document Type: Article

References (111)

1. Dixon JB. The effect of obesity on health outcomes. Mol Cell Endocrinol. 2010;316:104-108.
2. Sturm R. Increases in morbid obesity in the USA: 2000-2005. Public Health. 2007;121:492-496. (Pubitemid 46895458)
3. WHO. Obesity: preventing and managing the global epidemic: report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894: 1-253.
4. Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med. 1997;337:869-873. (Pubitemid 27408568)
5. Egger G, Dixon J. Non-nutrient causes of low-grade, systemic inflammation: support for a "canary in the mineshaft" view of obesity in chronic disease. Obes Rev. 2011;12:339-345.
6. Rosenbaum M, Hirsch J, Murphy E, Leibel RL. Effects of changes in body weight on carbohydrate metabolism, catecholamine excretion, and thyroid function. Am J Clin Nutr. 2000;71:1421-1432. (Pubitemid 30395887)
7. Rosenbaum M, Sy M, Pavlovich K, Leibel RL, Hirsch J. Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli. J Clin Invest. 2008;118:2583-2591. (Pubitemid 351949785)
8. James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP, Torp-Pedersen C, Sharma AM, Shepherd GM, Rode RA, Renz CL. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med. 2010;363:905-917.
9. Padwal R, Kezouh A, Levine M, Etminan M. Long-term persistence with orlistat and sibutramine in a population-based cohort. Int J Obes (Lond). 2007;31:1567-1570. (Pubitemid 47482652)
10. Amori RE, Lau J, Pittas AG. Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. JAMA. 2007;298: 194-206. (Pubitemid 47057766)
11. Klonoff DC, Greenway F. Drugs in the pipeline for the obesity market. J Diabetes Sci Technol. 2008;2:913-918.
12. Fielding G. The Lap-Band: technique. In: Deitel M, Gagner M, Dixon JB, Himpens J, Madan AK, eds. Handbook of Obesity Surgery. Toronto, Canada: FD-Communications Inc; 2010;1:15-21.
13. Flum DR, Belle SH, King WC, Wahed AS, Berk P, Chapman W, Pories W, Courcoulas A, McCloskey C, Mitchell J, Patterson E, Pomp A, Staten MA, Yanovski SZ, Thirlby R, Wolfe B. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009; 361:445-454.
14. DeMaria EJ, Pate V, Warthen M, Winegar DA. Baseline data from American Society for Metabolic and Bariatric Surgery-designated Bariatric Surgery Centers of Excellence using the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis. 2010;6:347-355.
15. Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2008. Obes Surg. 2009;19:1605-1611.
16. Hallberg D. Why the operation I prefer is adjustable gastric banding. Obes Surg. 1991;1:187-188.
17. Kuzmak LI. A review of seven years' experience with silicone gastric banding. Obes Surg. 1991;1:403-408.
18. Belachew M, Legrand M, Vincent V, Lismonde M, Le Docte N, Deschamps V. Laparoscopic adjustable gastric banding. World J Surg. 1998;22:955-963. (Pubitemid 28374613)
19. Arnstein NB, Shapiro B, Ekhauser FE, Dmuchowski CF, Knol JA, Strodel WE, Nakajo M, Swanson DP. Morbid obesity treated by gastroplasty: radionuclide gastric emptying studies. Radiology. 1985;156: 501-504. (Pubitemid 15230271)
20. Burton PR, Yap K, Brown WA, Laurie C, O'Donnell M, Hebbard G, Kalff V, O'Brien PE. Changes in satiety, supra-and infraband transit, and gastric emptying following laparoscopic adjustable gastric banding: a prospective follow-up study. Obes Surg. 2011;21:217-223.
21. Burton PR, Yap K, Brown WA, Laurie C, O'Donnell M, Hebbard G, Kalff V, O'Brien PE. Effects of adjustable gastric bands on gastric emptying, supra-and infraband transit and satiety: a randomized double-blind crossover trial using a new technique of band visualization. Obes Surg. 2010;20:1690-1697.
22. Dixon AF, Dixon JB, O'Brien PE. Laparoscopic adjustable gastric banding induces prolonged satiety: a randomized blind crossover study. J Clin Endocrinol Metab. 2005;90:813-819. (Pubitemid 40279202)
23. Dixon AF, le Roux CW, Ghatei MA, Bloom SR, McGee TL, Dixon JB. Pancreatic polypeptide meal response may predict gastric band-induced weight loss. Obes Surg. 2011;21:1906-1913.
24. Wang FB, Powley TL. Topographic inventories of vagal afferents in gastrointestinal muscle. J Comp Neurol. 2000;421:302-324. (Pubitemid 30253396)
25. Berthoud HR. Vagal and hormonal gut-brain communication: from satiation to satisfaction. Neurogastroenterol Motil. 2008;20(suppl 1):64-72.
26. Colles SL, Dixon JB, O'Brien PE. Hunger control and regular physical activity facilitate weight loss after laparoscopic adjustable gastric banding. Obes Surg. 2008;18:833-840.
27. NIH. Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference statement. Am J Clin Nutr. 1992;55(suppl):615S-619S.
28. Clinical Practice Guidelines for the Management of Overweight and Obesity in Adults. Canberra, Australia: National Health and Medical Research Council; 2003.
29. Obesity: Guidance on the Prevention, Identification, Assessment and Management of Overweight and Obesity in Adults and Children. London, YK: National Institute for Health and Clinical Excellence 2006.
30. Dixon JB, Zimmet P, Alberti KG, Rubino F. Bariatric surgery: an IDF statement for obese type 2 diabetes. Diabet Med. 2011;28:628-642.
31. US Food and Drug Administration. Premarket approval letter, LAP-BAND-Adjustable Gastric Banding System: P000008/S017. Silver Spring, MD: US Department of Health and Human Services; February 16, 2011.
32. Mechanick JI, Kushner RF, Sugerman HJ, Gonzalez-Campoy JM, Collazo-Clavell ML, Guven S, Spitz AF, Apovian CM, Livingston EH, Brolin R, Sarwer DB, Anderson WA, Dixon J. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Endocr Pract. 2008;14(suppl 1):1-83.
33. O'Brien PE, McPhail T, Chaston TB, Dixon JB. Systematic review of medium-term weight loss after bariatric operations. Obes Surg. 2006; 16:1032-1040. (Pubitemid 44221269)
34. O'Brien PE, Dixon JB, Brown W, Schachter LM, Chapman L, Burn AJ, Dixon ME, Scheinkestel C, Halket C, Sutherland LJ, Korin A, Baquie P. The laparoscopic adjustable gastric band (Lap-Band): a prospective study of medium-term effects on weight, health and quality of life. Obes Surg. 2002;12:652-660. (Pubitemid 35305744)
35. Toouli J, Kow L, Collins J, Schloithe A, Oppermann C. Efficacy of a low-pressure laparoscopic adjustable gastric band for morbid obesity: patients at long term in a multidisciplinary center. Surg Obes Relat Dis. 2008;4(suppl):S31-S38. (Pubitemid 351689960)
36. Favretti F, Segato G, Ashton D, Busetto L, De Luca M, Mazza M, Ceoloni A, Banzato O, Calo E, Enzi G. Laparoscopic adjustable gastric banding in 1,791 consecutive obese patients: 12-year results. Obes Surg. 2007;17:168-175. (Pubitemid 47091577)
37. Ponce J, Paynter S, Fromm R. Laparoscopic adjustable gastric banding: 1,014 consecutive cases. J Am Coll Surg. 2005;201:529-535. (Pubitemid 41393073)
38. Jan JC, Hong D, Bardaro SJ, July LV, Patterson EJ. Comparative study between laparoscopic adjustable gastric banding and laparoscopic gastric bypass: single-institution, 5-year experience in bariatric surgery. Surg Obes Relat Dis. 2007;3:42-50. (Pubitemid 46112411)
39. Himpens J, Dobbeleir J, Peeters G. Long-term results of laparoscopic sleeve gastrectomy for obesity. Ann Surg. 2010;252:319-324.
40. Chapman A, Kiroff G, Game P, Foster B, O'Brien P, Ham J, Maddern G. Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic review. Surgery. 2004;135:326-351. (Pubitemid 38297385)
41. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724-1737. (Pubitemid 39346675)
42. Cunneen SA. Review of meta-analytic comparisons of bariatric surgery with a focus on laparoscopic adjustable gastric banding. Surg Obes Relat Dis. 2008;4(suppl):S47-S55. (Pubitemid 351689962)
43. Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007;142:621-632.
44. Peeters A, O'Brien PE, Laurie C, Anderson M, Wolfe R, Flum D, Macinnis RJ, English DR, Dixon JB. Substantial intentional weight loss and mortality in the severely obese. Ann Surg. 2007;246:1028-1033. (Pubitemid 350179196)
45. Busetto L, Mirabelli D, Petroni ML, Mazza M, Favretti F, Segato G, Chiusolo M, Merletti F, Balzola F, Enzi G. Comparative long-term mortality after laparoscopic adjustable gastric banding versus nonsurgical controls. Surg Obes Relat Dis. 2007;3:496-450.
46. Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lonroth H, Naslund I, Olbers T, Stenlof K, Torgerson J, Agren G, Carlsson LM. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741-752. (Pubitemid 47295641)
47. Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, Lamonte MJ, Stroup AM, Hunt SC. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753-761. (Pubitemid 47295642)
48. Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, Clegg AJ. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009;13:1-190, 215-357, iii-iv.
49. O'Brien PE, Dixon JB, Laurie C, Skinner S, Proietto J, McNeil J, Strauss B, Marks S, Schachter L, Chapman L, Anderson M. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med. 2006;144:625-633. (Pubitemid 46780646)
50. O'Brien PE, Sawyer SM, Laurie C, Brown WA, Skinner S, Veit F, Paul E, Burton PR, McGrice M, Anderson M, Dixon JB. Laparoscopic adjustable gastric banding in severely obese adolescents: a randomized trial. JAMA. 2010;303:519-526.
51. Dixon JB, O'Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, Proietto J, Bailey M, Anderson M. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299:316-323. (Pubitemid 351159368)
52. Sharma AM. M, M, M & M: a mnemonic for assessing obesity. Obes Rev. 2010;11:808-809.
53. Dixon JB, Anderson M, Cameron-Smith D, O'Brien PE. Sustained weight loss in obese subjects has benefits that are independent of attained weight. Obes Res. 2004;12:1895-1902. (Pubitemid 41133041)
54. Dixon JB, O'Brien PE. Changes in comorbidities and improvements in quality of life after LAP-BAND placement. Am J Surg. 2002;184: S51-S54.
55. Chen SB, Lee YC, Ser KH, Chen JC, Chen SC, Hsieh HF, Lee WJ. Serum C-reactive protein and white blood cell count in morbidly obese surgical patients. Obes Surg. 2009;19:461-466.
56. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122: 248.e5-256.e5.
57. Dixon JB, O'Brien P. Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care. 2002;25:358-363. (Pubitemid 41079636)
58. Schlaich MP, Grassi G, Lambert GW, Straznicky N, Esler MD, Dixon J, Lambert EA, Redon J, Narkiewicz K, Jordan J. European Society of Hypertension Working Group on Obesity obesity-induced hypertension and target organ damage: current knowledge and future directions. J Hypertens. 2009;27:207-211.
59. Livingston EH, Chandalia M, Abate N. Do current body mass index criteria for obesity surgery reflect cardiovascular risk? Surg Obes Relat Dis. 2007;3:577-585. (Pubitemid 350091415)
60. Dixon JB, O'Brien PE. Lipid profile in the severely obese: changes with weight loss after lap-band surgery. Obes Res. 2002;10:903-910. (Pubitemid 135688904)
61. Greenburg DL, Lettieri CJ, Eliasson AH. Effects of surgical weight loss on measures of obstructive sleep apnea: a meta-analysis. Am J Med. 2009;122:535-542.
62. Oreopoulos A, Kalantar-Zadeh K, Sharma AM, Fonarow GC. The obesity paradox in the elderly: potential mechanisms and clinical implications. Clin Geriatr Med. 2009;25:643-659, viii.
63. Uretsky S, Messerli FH, Bangalore S, Champion A, Cooper-Dehoff RM, Zhou Q, Pepine CJ. Obesity paradox in patients with hypertension and coronary artery disease. Am J Med. 2007;120:863-870. (Pubitemid 47451305)
64. Artham SM, Lavie CJ, Milani RV, Ventura HO. The obesity paradox: impact of obesity on the prevalence and prognosis of cardiovascular diseases. Postgrad Med. 2008;120:34-41.
65. Buchwald H. Consensus conference statement bariatric surgery for morbid obesity: health implications for patients, health professionals, and third-party payers. Surg Obes Relat Dis. 2005;1:371-381.
66. Kolotkin RL, Crosby RD, Gress RE, Hunt SC, Adams TD. Two-year changes in health-related quality of life in gastric bypass patients compared with severely obese controls. Surg Obes Relat Dis. 2009;5: 250-256.
67. Dixon JB, Dixon ME, O'Brien PE. Body image: appearance orientation and evaluation in the severely obese: changes with weight loss. Obes Surg. 2002;12:65-71. (Pubitemid 34155264)
68. Colles SL, Dixon JB, O'Brien PE. Grazing and loss of control related to eating: two high-risk factors following bariatric surgery. Obesity (Silver Spring). 2008;16:615-622. (Pubitemid 351328012)
69. Dixon JB, Dixon ME, O'Brien PE. Depression in association with severe obesity: changes with weight loss. Arch Intern Med. 2003;163: 2058-2065. (Pubitemid 37151248)
70. Dixon JB, Dixon ME, O'Brien PE. Quality of life after Lap-Band placement: influence of time, weight loss, and comorbidities. Obes Res. 2001;9:713-721. (Pubitemid 33612304)
71. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA. 2003;289:187-193. (Pubitemid 36068706)
72. Dixon J. Survival advantage with bariatric surgery: report from the 10th International Congress on Obesity. Surg Obes Relat Dis. 2006;2: 585-586. (Pubitemid 44804167)
73. Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord. 1992;16:397-415.
74. Colagiuri S, Lee CM, Colagiuri R, Magliano D, Shaw JE, Zimmet PZ, Caterson ID. The cost of overweight and obesity in Australia. Med J Aust. 2010;192:260-264.
75. Tsai AG, Williamson DF, Glick HA. Direct medical cost of overweight and obesity in the USA: a quantitative systematic review. Obes Rev. 2011;12:50-61.
76. Trogdon JG, Finkelstein EA, Hylands T, Dellea PS, Kamal-Bahl SJ. Indirect costs of obesity: a review of the current literature. Obes Rev. 2008;9:489-500.
77. Cremieux PY, Buchwald H, Shikora SA, Ghosh A, Yang HE, Buessing M. A study on the economic impact of bariatric surgery. Am J Manag Care. 2008;14:589-596.
78. Keating CL, Dixon JB, Moodie ML, Peeters A, Bulfone L, Maglianno DJ, O'Brien PE. Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis. Diabetes Care. 2009;32:567-574.
79. Finkelstein EA, Allaire BT, Burgess SM, Hale BC. Financial implications of coverage for laparoscopic adjustable gastric banding. Surg Obes Relat Dis. 2011;7:295-303.
80. Anselmino M, Bammer T, Fernandez Cebrian JM, Daoud F, Romagnoli G, Torres A. Cost-effectiveness and budget impact of obesity surgery in patients with type 2 diabetes in three European countries (II). Obes Surg. 2009;19:1542-1549.
81. Salem L, Devlin A, Sullivan SD, Flum DR. Cost-effectiveness analysis of laparoscopic gastric bypass, adjustable gastric banding, and nonoperative weight loss interventions. Surg Obes Relat Dis. 2008;4:26-32.
82. Finkelstein EA, Brown DS. Return on investment for bariatric surgery. Am J Manag Care. 2008;14:561-562.
83. Watkins BM, Ahroni JH, Michaelson R, Montgomery KF, Abrams RE, Erlitz MD, Scurlock JE. Laparoscopic adjustable gastric banding in an ambulatory surgery center. Surg Obes Relat Dis. 2008;4(suppl): S56-S62. (Pubitemid 351689963)
84. Cobourn C, Mumford D, Chapman MA, Wells L. Laparoscopic gastric banding is safe in outpatient surgical centers. Obes Surg. 2010;20: 415-422.
85. Dolan JP, Diggs BS, Sheppard BC, Hunter JG. The national mortality burden and significant factors associated with open and laparoscopic cholecystectomy: 1997-2006. J Gastrointest Surg. 2009;13:2292-2301.
86. Lancaster RT, Hutter MM. Bands and bypasses: 30-day morbidity and mortality of bariatric surgical procedures as assessed by prospective, multi-center, risk-adjusted ACS-NSQIP data. Surg Endosc. 2008;22: 2554-2563.
87. Demaria EJ, Winegar DA, Pate VW, Hutcher NE, Ponce J, Pories WJ. Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the Bariatric Outcomes Longitudinal Database. Ann Surg. 2010;252:559-566.
88. Parikh MS, Laker S, Weiner M, Hajiseyedjavadi O, Ren CJ. Objective comparison of complications resulting from laparoscopic bariatric procedures. J Am Coll Surg. 2006;202:252-261. (Pubitemid 43112484)
89. DeMaria EJ, Portenier D, Wolfe L. Obesity surgery mortality risk score: proposal for a clinically useful score to predict mortality risk in patients undergoing gastric bypass. Surg Obes Relat Dis. 2007;3:134-140. (Pubitemid 46444703)
90. Brown WA, Burton PR, Anderson M, Korin A, Dixon JB, Hebbard G, O'Brien PE. Symmetrical pouch dilatation after laparoscopic adjustable gastric banding: incidence and management. Obes Surg. 2008;18: 1104-1108.
91. Singhal R, Bryant C, Kitchen M, Khan KS, Deeks J, Guo B, Super P. Band slippage and erosion after laparoscopic gastric banding: a metaanalysis. Surg Endosc. 2010;24:2980-2986.
92. Kirshtein B, Lantsberg L, Mizrahi S, Avinoach E. Bariatric emergencies for non-bariatric surgeons: complications of laparoscopic gastric banding. Obes Surg. 2010;20:1468-1478.
93. Kriwanek S, Schermann M, Ali Abdullah S, Roka R. Band slippage: a potentially life-threatening complication after laparoscopic adjustable gastric banding. Obes Surg. 2005;15:133-136. (Pubitemid 40203839)
94. Egberts K, Brown WA, O'Brien PE. Systematic review of erosion after laparoscopic adjustable gastric banding. Obes Surg. 2011;21: 1272-1279.
95. Lyass S, Cunneen SA, Hagiike M, Misra M, Burch M, Khalili TM, Furman G, Phillips EH. Device-related reoperations after laparoscopic adjustable gastric banding. Am Surg. 2005;71:738-743.
96. Westling A, Bjurling K, Ohrvall M, Gustavsson S. Silicone-adjustable gastric banding: disappointing results. Obes Surg. 1998;8:467-474. (Pubitemid 28421174)
97. DeMaria EJ, Sugerman HJ, Meador JG, Doty JM, Kellum JM, Wolfe L, Szucs RA, Turner MA. High failure rate after laparoscopic adjustable silicone gastric banding for treatment of morbid obesity. Ann Surg. 2001;233:809-818. (Pubitemid 32494562)
98. Dixon JB, Dixon ME, O'Brien PE. Birth outcomes in obese women after laparoscopic adjustable gastric banding. Obstet Gynecol. 2005;106: 965-972. (Pubitemid 41532901)
99. Aills L, Blankenship J, Buffington C, Furtado M, Parrott J. ASMBS allied health nutritional guidelines for the surgical weight loss patient. Surg Obes Relat Dis. 2008;4(suppl):S73-S108.
100. Lindor KD, Hughes RW Jr, Ilstrup DM, Jensen MD. Intragastric balloons in comparison with standard therapy for obesity: a randomized, double-blind trial. Mayo Clin Proc. 1987;62:992-996. (Pubitemid 18045434)
101. Schapiro B, Blackburn G, Frank B, Heber D, Kozarek R. Obesity and the gastric balloon: a comprehensive workshop. Gastrointest Endosc. 1987;33:323-327. (Pubitemid 17122437)
102. Dumonceau JM. Evidence-based review of the Bioenterics intragastric balloon for weight loss. Obes Surg. 2008;18:1611-1617.
103. De Castro ML, Morales MJ, Del Campo V, Pineda JR, Pena E, Sierra JM, Arbones MJ, Prada IR. Efficacy, safety, and tolerance of two types of intragastric balloons placed in obese subjects: a double-blind comparative study. Obes Surg. 2010;20:1642-1646.
104. Machytka E, Klvana P, Kornbluth A, Peikin S, Mathus-Vliegen LE, Gostout C, Lopez-Nava G, Shikora S, Brooks J. Adjustable intragastric balloons: a 12-month pilot trial in endoscopic weight loss management. Obes Surg. 2011;21:1499-1507.
105. Gersin KS, Rothstein RI, Rosenthal RJ, Stefanidis D, Deal SE, Kuwada TS, Laycock W, Adrales G, Vassiliou M, Szomstein S, Heller S, Joyce AM, Heiss F, Nepomnayshy D. Open-label, shamcontrolled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates. Gastrointest Endosc. 2010;71:976-982.
106. Schouten R, Rijs CS, Bouvy ND, Hameeteman W, Koek GH, Janssen IM, Greve JW. A multicenter, randomized efficacy study of the Endo-Barrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery. Ann Surg. 2010;251:236-243.
107. Tsesmeli N, Coumaros D. The future of bariatrics: endoscopy, endoluminal surgery, and natural orifice transluminal endoscopic surgery. Endoscopy. 2010;42:155-162.
108. Shikora SA. Implantable gastric stimulation for weight loss. J Gastrointest Surg. 2004;8:408-412. (Pubitemid 38561203)
109. Zhang J, Chen JD. Systematic review: applications and future of gastric electrical stimulation. Aliment Pharmacol Ther. 2006;24:991-1002. (Pubitemid 44386524)
110. Sanmiguel CP, Conklin JL, Cunneen SA, Barnett P, Phillips EH, Kipnes M, Pilcher J, Soffer EE. Gastric electrical stimulation with the TANTALUS System in obese type 2 diabetes patients: effect on weight and glycemic control. J Diabetes Sci Technol. 2009;3:964-970.
111. Camilleri M, Toouli J, Herrera MF, Kulseng B, Kow L, Pantoja JP, Marvik R, Johnsen G, Billington CJ, Moody FG, Knudson MB, Tweden KS, Vollmer M, Wilson RR, Anvari M. Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device. Surgery. 2008;143:723-731.